Sophorolipid Comprehensive Study by Type (Natural Sedimentation Method, Centrifugation Method, Membrane Filtration Method, Other), End Users (Oil, Medicine, Food, Cosmetics, Home Care, Agricultural, Feed, Other) Players and Region - Global Market Outlook to 2026

Sophorolipid Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Key Vendors of Sophorolipid Market Study:
Evonik (Germany), Saraya Co., Ltd. (Japan), Ecover (Belgium), Allied Carbon Solutions (Japan), MG Intobio (United Kingdom), SyntheZyme LLC (United Kingdom), Henkel (Germany), AGAE Technologies (United States), Biotensidon (Germany) and Jeneil Biotech (United States)

In the last few years, Global market of Sophorolipid developed rapidly. Major factors driving the market are Increasing importance of cleaning agents .

On the basis of product type, the Sophorolipid market is segmented by Natural Sedimentation Method, Centrifugation Method, Membrane Filtration Method and Other.
Some of the other players that are also part of study are Logos Technologies (United States) and Saraya Co. (Japan).

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Sophorolipid market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Sophorolipid market.
Identification of total players or companies operating in the global market which is further concentrated to a fewer or most impacting players which is considered under the report’s scope. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organizations, Government Agencies and Organizations.

This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Natural Sedimentation Method
  • Centrifugation Method
  • Membrane Filtration Method
  • Other
By End Users
  • Oil
  • Medicine
  • Food
  • Cosmetics
  • Home Care
  • Agricultural
  • Feed
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing importance of cleaning agents
      • 3.2.2. Growing deployment for bio remediation
    • 3.3. Market Challenges
      • 3.3.1. Increasing adoption of hamnolipids, mannosylerythritol lipids and trehalose lipids may hamper the market
    • 3.4. Market Trends
      • 3.4.1. Increasing usage of personal care products is enhancing the market growth
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sophorolipid, by Type, End Users and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Sophorolipid (Value)
      • 5.2.1. Global Sophorolipid by: Type (Value)
        • 5.2.1.1. Natural Sedimentation Method
        • 5.2.1.2. Centrifugation Method
        • 5.2.1.3. Membrane Filtration Method
        • 5.2.1.4. Other
      • 5.2.2. Global Sophorolipid by: End Users (Value)
        • 5.2.2.1. Oil
        • 5.2.2.2. Medicine
        • 5.2.2.3. Food
        • 5.2.2.4. Cosmetics
        • 5.2.2.5. Home Care
        • 5.2.2.6. Agricultural
        • 5.2.2.7. Feed
        • 5.2.2.8. Other
      • 5.2.3. Global Sophorolipid Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Sophorolipid: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Evonik (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Saraya Co., Ltd. (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ecover (Belgium)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Allied Carbon Solutions (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. MG Intobio (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. SyntheZyme LLC (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Henkel (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AGAE Technologies (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Biotensidon (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Jeneil Biotech (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Sophorolipid Sale, by Type, End Users and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Sophorolipid (Value)
      • 7.2.1. Global Sophorolipid by: Type (Value)
        • 7.2.1.1. Natural Sedimentation Method
        • 7.2.1.2. Centrifugation Method
        • 7.2.1.3. Membrane Filtration Method
        • 7.2.1.4. Other
      • 7.2.2. Global Sophorolipid by: End Users (Value)
        • 7.2.2.1. Oil
        • 7.2.2.2. Medicine
        • 7.2.2.3. Food
        • 7.2.2.4. Cosmetics
        • 7.2.2.5. Home Care
        • 7.2.2.6. Agricultural
        • 7.2.2.7. Feed
        • 7.2.2.8. Other
      • 7.2.3. Global Sophorolipid Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sophorolipid: by Type(USD Million)
  • Table 2. Sophorolipid Natural Sedimentation Method , by Region USD Million (2015-2020)
  • Table 3. Sophorolipid Centrifugation Method , by Region USD Million (2015-2020)
  • Table 4. Sophorolipid Membrane Filtration Method , by Region USD Million (2015-2020)
  • Table 5. Sophorolipid Other , by Region USD Million (2015-2020)
  • Table 6. Sophorolipid: by End Users(USD Million)
  • Table 7. Sophorolipid Oil , by Region USD Million (2015-2020)
  • Table 8. Sophorolipid Medicine , by Region USD Million (2015-2020)
  • Table 9. Sophorolipid Food , by Region USD Million (2015-2020)
  • Table 10. Sophorolipid Cosmetics , by Region USD Million (2015-2020)
  • Table 11. Sophorolipid Home Care , by Region USD Million (2015-2020)
  • Table 12. Sophorolipid Agricultural , by Region USD Million (2015-2020)
  • Table 13. Sophorolipid Feed , by Region USD Million (2015-2020)
  • Table 14. Sophorolipid Other , by Region USD Million (2015-2020)
  • Table 15. South America Sophorolipid, by Country USD Million (2015-2020)
  • Table 16. South America Sophorolipid, by Type USD Million (2015-2020)
  • Table 17. South America Sophorolipid, by End Users USD Million (2015-2020)
  • Table 18. Brazil Sophorolipid, by Type USD Million (2015-2020)
  • Table 19. Brazil Sophorolipid, by End Users USD Million (2015-2020)
  • Table 20. Argentina Sophorolipid, by Type USD Million (2015-2020)
  • Table 21. Argentina Sophorolipid, by End Users USD Million (2015-2020)
  • Table 22. Rest of South America Sophorolipid, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Sophorolipid, by End Users USD Million (2015-2020)
  • Table 24. Asia Pacific Sophorolipid, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Sophorolipid, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Sophorolipid, by End Users USD Million (2015-2020)
  • Table 27. China Sophorolipid, by Type USD Million (2015-2020)
  • Table 28. China Sophorolipid, by End Users USD Million (2015-2020)
  • Table 29. Japan Sophorolipid, by Type USD Million (2015-2020)
  • Table 30. Japan Sophorolipid, by End Users USD Million (2015-2020)
  • Table 31. India Sophorolipid, by Type USD Million (2015-2020)
  • Table 32. India Sophorolipid, by End Users USD Million (2015-2020)
  • Table 33. South Korea Sophorolipid, by Type USD Million (2015-2020)
  • Table 34. South Korea Sophorolipid, by End Users USD Million (2015-2020)
  • Table 35. Taiwan Sophorolipid, by Type USD Million (2015-2020)
  • Table 36. Taiwan Sophorolipid, by End Users USD Million (2015-2020)
  • Table 37. Australia Sophorolipid, by Type USD Million (2015-2020)
  • Table 38. Australia Sophorolipid, by End Users USD Million (2015-2020)
  • Table 39. Rest of Asia-Pacific Sophorolipid, by Type USD Million (2015-2020)
  • Table 40. Rest of Asia-Pacific Sophorolipid, by End Users USD Million (2015-2020)
  • Table 41. Europe Sophorolipid, by Country USD Million (2015-2020)
  • Table 42. Europe Sophorolipid, by Type USD Million (2015-2020)
  • Table 43. Europe Sophorolipid, by End Users USD Million (2015-2020)
  • Table 44. Germany Sophorolipid, by Type USD Million (2015-2020)
  • Table 45. Germany Sophorolipid, by End Users USD Million (2015-2020)
  • Table 46. France Sophorolipid, by Type USD Million (2015-2020)
  • Table 47. France Sophorolipid, by End Users USD Million (2015-2020)
  • Table 48. Italy Sophorolipid, by Type USD Million (2015-2020)
  • Table 49. Italy Sophorolipid, by End Users USD Million (2015-2020)
  • Table 50. United Kingdom Sophorolipid, by Type USD Million (2015-2020)
  • Table 51. United Kingdom Sophorolipid, by End Users USD Million (2015-2020)
  • Table 52. Netherlands Sophorolipid, by Type USD Million (2015-2020)
  • Table 53. Netherlands Sophorolipid, by End Users USD Million (2015-2020)
  • Table 54. Rest of Europe Sophorolipid, by Type USD Million (2015-2020)
  • Table 55. Rest of Europe Sophorolipid, by End Users USD Million (2015-2020)
  • Table 56. MEA Sophorolipid, by Country USD Million (2015-2020)
  • Table 57. MEA Sophorolipid, by Type USD Million (2015-2020)
  • Table 58. MEA Sophorolipid, by End Users USD Million (2015-2020)
  • Table 59. Middle East Sophorolipid, by Type USD Million (2015-2020)
  • Table 60. Middle East Sophorolipid, by End Users USD Million (2015-2020)
  • Table 61. Africa Sophorolipid, by Type USD Million (2015-2020)
  • Table 62. Africa Sophorolipid, by End Users USD Million (2015-2020)
  • Table 63. North America Sophorolipid, by Country USD Million (2015-2020)
  • Table 64. North America Sophorolipid, by Type USD Million (2015-2020)
  • Table 65. North America Sophorolipid, by End Users USD Million (2015-2020)
  • Table 66. United States Sophorolipid, by Type USD Million (2015-2020)
  • Table 67. United States Sophorolipid, by End Users USD Million (2015-2020)
  • Table 68. Canada Sophorolipid, by Type USD Million (2015-2020)
  • Table 69. Canada Sophorolipid, by End Users USD Million (2015-2020)
  • Table 70. Mexico Sophorolipid, by Type USD Million (2015-2020)
  • Table 71. Mexico Sophorolipid, by End Users USD Million (2015-2020)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Sophorolipid: by Type(USD Million)
  • Table 83. Sophorolipid Natural Sedimentation Method , by Region USD Million (2021-2026)
  • Table 84. Sophorolipid Centrifugation Method , by Region USD Million (2021-2026)
  • Table 85. Sophorolipid Membrane Filtration Method , by Region USD Million (2021-2026)
  • Table 86. Sophorolipid Other , by Region USD Million (2021-2026)
  • Table 87. Sophorolipid: by End Users(USD Million)
  • Table 88. Sophorolipid Oil , by Region USD Million (2021-2026)
  • Table 89. Sophorolipid Medicine , by Region USD Million (2021-2026)
  • Table 90. Sophorolipid Food , by Region USD Million (2021-2026)
  • Table 91. Sophorolipid Cosmetics , by Region USD Million (2021-2026)
  • Table 92. Sophorolipid Home Care , by Region USD Million (2021-2026)
  • Table 93. Sophorolipid Agricultural , by Region USD Million (2021-2026)
  • Table 94. Sophorolipid Feed , by Region USD Million (2021-2026)
  • Table 95. Sophorolipid Other , by Region USD Million (2021-2026)
  • Table 96. South America Sophorolipid, by Country USD Million (2021-2026)
  • Table 97. South America Sophorolipid, by Type USD Million (2021-2026)
  • Table 98. South America Sophorolipid, by End Users USD Million (2021-2026)
  • Table 99. Brazil Sophorolipid, by Type USD Million (2021-2026)
  • Table 100. Brazil Sophorolipid, by End Users USD Million (2021-2026)
  • Table 101. Argentina Sophorolipid, by Type USD Million (2021-2026)
  • Table 102. Argentina Sophorolipid, by End Users USD Million (2021-2026)
  • Table 103. Rest of South America Sophorolipid, by Type USD Million (2021-2026)
  • Table 104. Rest of South America Sophorolipid, by End Users USD Million (2021-2026)
  • Table 105. Asia Pacific Sophorolipid, by Country USD Million (2021-2026)
  • Table 106. Asia Pacific Sophorolipid, by Type USD Million (2021-2026)
  • Table 107. Asia Pacific Sophorolipid, by End Users USD Million (2021-2026)
  • Table 108. China Sophorolipid, by Type USD Million (2021-2026)
  • Table 109. China Sophorolipid, by End Users USD Million (2021-2026)
  • Table 110. Japan Sophorolipid, by Type USD Million (2021-2026)
  • Table 111. Japan Sophorolipid, by End Users USD Million (2021-2026)
  • Table 112. India Sophorolipid, by Type USD Million (2021-2026)
  • Table 113. India Sophorolipid, by End Users USD Million (2021-2026)
  • Table 114. South Korea Sophorolipid, by Type USD Million (2021-2026)
  • Table 115. South Korea Sophorolipid, by End Users USD Million (2021-2026)
  • Table 116. Taiwan Sophorolipid, by Type USD Million (2021-2026)
  • Table 117. Taiwan Sophorolipid, by End Users USD Million (2021-2026)
  • Table 118. Australia Sophorolipid, by Type USD Million (2021-2026)
  • Table 119. Australia Sophorolipid, by End Users USD Million (2021-2026)
  • Table 120. Rest of Asia-Pacific Sophorolipid, by Type USD Million (2021-2026)
  • Table 121. Rest of Asia-Pacific Sophorolipid, by End Users USD Million (2021-2026)
  • Table 122. Europe Sophorolipid, by Country USD Million (2021-2026)
  • Table 123. Europe Sophorolipid, by Type USD Million (2021-2026)
  • Table 124. Europe Sophorolipid, by End Users USD Million (2021-2026)
  • Table 125. Germany Sophorolipid, by Type USD Million (2021-2026)
  • Table 126. Germany Sophorolipid, by End Users USD Million (2021-2026)
  • Table 127. France Sophorolipid, by Type USD Million (2021-2026)
  • Table 128. France Sophorolipid, by End Users USD Million (2021-2026)
  • Table 129. Italy Sophorolipid, by Type USD Million (2021-2026)
  • Table 130. Italy Sophorolipid, by End Users USD Million (2021-2026)
  • Table 131. United Kingdom Sophorolipid, by Type USD Million (2021-2026)
  • Table 132. United Kingdom Sophorolipid, by End Users USD Million (2021-2026)
  • Table 133. Netherlands Sophorolipid, by Type USD Million (2021-2026)
  • Table 134. Netherlands Sophorolipid, by End Users USD Million (2021-2026)
  • Table 135. Rest of Europe Sophorolipid, by Type USD Million (2021-2026)
  • Table 136. Rest of Europe Sophorolipid, by End Users USD Million (2021-2026)
  • Table 137. MEA Sophorolipid, by Country USD Million (2021-2026)
  • Table 138. MEA Sophorolipid, by Type USD Million (2021-2026)
  • Table 139. MEA Sophorolipid, by End Users USD Million (2021-2026)
  • Table 140. Middle East Sophorolipid, by Type USD Million (2021-2026)
  • Table 141. Middle East Sophorolipid, by End Users USD Million (2021-2026)
  • Table 142. Africa Sophorolipid, by Type USD Million (2021-2026)
  • Table 143. Africa Sophorolipid, by End Users USD Million (2021-2026)
  • Table 144. North America Sophorolipid, by Country USD Million (2021-2026)
  • Table 145. North America Sophorolipid, by Type USD Million (2021-2026)
  • Table 146. North America Sophorolipid, by End Users USD Million (2021-2026)
  • Table 147. United States Sophorolipid, by Type USD Million (2021-2026)
  • Table 148. United States Sophorolipid, by End Users USD Million (2021-2026)
  • Table 149. Canada Sophorolipid, by Type USD Million (2021-2026)
  • Table 150. Canada Sophorolipid, by End Users USD Million (2021-2026)
  • Table 151. Mexico Sophorolipid, by Type USD Million (2021-2026)
  • Table 152. Mexico Sophorolipid, by End Users USD Million (2021-2026)
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sophorolipid: by Type USD Million (2015-2020)
  • Figure 5. Global Sophorolipid: by End Users USD Million (2015-2020)
  • Figure 6. South America Sophorolipid Share (%), by Country
  • Figure 7. Asia Pacific Sophorolipid Share (%), by Country
  • Figure 8. Europe Sophorolipid Share (%), by Country
  • Figure 9. MEA Sophorolipid Share (%), by Country
  • Figure 10. North America Sophorolipid Share (%), by Country
  • Figure 11. Global Sophorolipid share by Players 2020 (%)
  • Figure 12. Global Sophorolipid share by Players (Top 3) 2020(%)
  • Figure 13. Global Sophorolipid share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Evonik (Germany) Revenue, Net Income and Gross profit
  • Figure 16. Evonik (Germany) Revenue: by Geography 2020
  • Figure 17. Saraya Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Saraya Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 19. Ecover (Belgium) Revenue, Net Income and Gross profit
  • Figure 20. Ecover (Belgium) Revenue: by Geography 2020
  • Figure 21. Allied Carbon Solutions (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Allied Carbon Solutions (Japan) Revenue: by Geography 2020
  • Figure 23. MG Intobio (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. MG Intobio (United Kingdom) Revenue: by Geography 2020
  • Figure 25. SyntheZyme LLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. SyntheZyme LLC (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Henkel (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Henkel (Germany) Revenue: by Geography 2020
  • Figure 29. AGAE Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 30. AGAE Technologies (United States) Revenue: by Geography 2020
  • Figure 31. Biotensidon (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Biotensidon (Germany) Revenue: by Geography 2020
  • Figure 33. Jeneil Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 34. Jeneil Biotech (United States) Revenue: by Geography 2020
  • Figure 35. Global Sophorolipid: by Type USD Million (2021-2026)
  • Figure 36. Global Sophorolipid: by End Users USD Million (2021-2026)
  • Figure 37. South America Sophorolipid Share (%), by Country
  • Figure 38. Asia Pacific Sophorolipid Share (%), by Country
  • Figure 39. Europe Sophorolipid Share (%), by Country
  • Figure 40. MEA Sophorolipid Share (%), by Country
  • Figure 41. North America Sophorolipid Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Evonik (Germany)
  • Saraya Co., Ltd. (Japan)
  • Ecover (Belgium)
  • Allied Carbon Solutions (Japan)
  • MG Intobio (United Kingdom)
  • SyntheZyme LLC (United Kingdom)
  • Henkel (Germany)
  • AGAE Technologies (United States)
  • Biotensidon (Germany)
  • Jeneil Biotech (United States)
Additional players considered in the study are as follows:
Logos Technologies (United States) , Saraya Co. (Japan)
Select User Access Type

Key Highlights of Report


Jan 2022 225 Pages 85 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing usage of personal care products is enhancing the market growth" is seen as one of major influencing trends for Sophorolipid Market during projected period 2020-2026.
The Concentration Rate of Global Sophorolipid market is highlighted using HHI Index.
Vendors will contribute the maximum growth of Global Sophorolipid market throughout the predicted period.

Know More About Global Sophorolipid Market Report?